| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Introduction
|
Benagiano, G.
|
|
1995
|
51 |
S1 |
p. S1-
1 p.
|
article
|
| 2 |
List of participants
|
|
|
1995
|
51 |
S1 |
p. S75-S77
3 p.
|
article
|
| 3 |
New methods for transcervical cannulation of the Fallopian tube
|
Kerin, J.F.
|
|
1995
|
51 |
S1 |
p. S29-S39
11 p.
|
article
|
| 4 |
Quinacrine: sclerosing agent of the utero-tubal junction in women, with anticarcinogenic actions in transplanted tumors in mice
|
Zipper, J.
|
|
1995
|
51 |
S1 |
p. S47-S55
9 p.
|
article
|
| 5 |
Specifications for new technologies for female sterilization for use in developing countries
|
Dusitsin, N.
|
|
1995
|
51 |
S1 |
p. S15-S16
2 p.
|
article
|
| 6 |
The development of new technologies for female sterilization: conclusions and recommendations for research
|
Wilson, E.W.
|
|
1995
|
51 |
S1 |
p. S71-S74
4 p.
|
article
|
| 7 |
The evolution of methods for female sterilization
|
Wilson, E.W.
|
|
1995
|
51 |
S1 |
p. S3-S13
11 p.
|
article
|
| 8 |
The potential for improved abdominal procedures and approaches for tubal occlusion
|
Steele, S.J.
|
|
1995
|
51 |
S1 |
p. S17-S22
6 p.
|
article
|
| 9 |
Toxicological requirements for sclerosing agents or other chemicals for female sterilization
|
Heywood, R.
|
|
1995
|
51 |
S1 |
p. S41-S45
5 p.
|
article
|
| 10 |
Transcervical quinacrine sterilization: clinical experience
|
Sokal, D.C.
|
|
1995
|
51 |
S1 |
p. S57-S69
13 p.
|
article
|
| 11 |
Update on transcervical sterilization
|
Neuwirth, R.S.
|
|
1995
|
51 |
S1 |
p. S23-S28
6 p.
|
article
|
Journal description